Newsroom

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of BlackRock TCP Capital Corp. (NASDAQ: TCPC) between November 6, 2024, and January 23, 2026, inclusive (the “Class Period”). BlackRock TCP is a business development company.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is Investigating the Allegations...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of American Depositary Shares (“ADS”) of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023, and December 26, 2025. Mereo describes itself as a “biopharmaceutical company focused on the development of therapeutics for rare diseases.”For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Alle...

SNOQUALMIE, Wash.--(BUSINESS WIRE)--Spacelabs Healthcare today announced that it has signed an agreement with DEPTH Health, Inc., a leader in patient traffic flow optimization technology, that will allow DEPTH Health to provide hospitals and health systems the Rothman Index® through its DEPTH’s Real-Time Advisor for Clinical Expert Routing (RACER™) offering. Spacelabs Healthcare’s Rothman Index is an advanced application that is designed to help healthcare providers identify subtle changes in a...

METAIRIE, La.--(BUSINESS WIRE)--Biloxi Marsh Lands Corporation Announces Date of 2026 Annual Meeting of Shareholders, Results for the fourth quarter and year ended December 31, 2025...

LADERA RANCH, Calif.--(BUSINESS WIRE)--Strategic Storage Trust VI, Inc. Reports Year Ended December 31, 2025 Results...

MIAMI--(BUSINESS WIRE)--CIM Group and its partners in Miami Worldcenter have sold retail and entertainment district component of the 27-acre development in downtown Miami....

BOCA RATON, Fla.--(BUSINESS WIRE)--Allevion Medical today announced the FDA clearance of Vantage™, a fully disposable, sterile system designed to simplify and enhance minimally invasive lumbar decompression procedures. Developed to address pain associated with hypertrophic bone growth, Vantage™ enables targeted decompression through a patented approach that combines precision with procedural control. The system follows an intuitive, reproducible workflow—locate, dilate, decompress—that helps ph...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today confirmed that its definitive annual results for the fiscal year ended 2025 are in line with the estimated figures published on March 27, 2026. Confirmation of Results The definitive consolidated and individual...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible au PEA-PME), une société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les maladies rétiniennes neurodégénératives et les troubles du système nerveux central, a confirmé aujourd'hui que ses résultats annuels définitifs pour l'exercice clos en 2025 sont en ligne avec les chiffres estimés publiés le 27 mars 2026. Confirmat...

LONG BEACH, Calif.--(BUSINESS WIRE)--Si2 announces that registration is now open for the 2026 International Compact Modeling Conference (ICMC)...